311 related articles for article (PubMed ID: 29322843)
1. Immunotherapy for brain tumors: understanding early successes and limitations.
Lieberman NAP; Vitanza NA; Crane CA
Expert Rev Neurother; 2018 Mar; 18(3):251-259. PubMed ID: 29322843
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy as a New Therapeutic Approach for Brain and Spinal Cord Tumors.
Medikonda R; Pant A; Lim M
Adv Exp Med Biol; 2023; 1394():73-84. PubMed ID: 36587382
[TBL] [Abstract][Full Text] [Related]
3. The Safety of available immunotherapy for the treatment of glioblastoma.
Farber SH; Elsamadicy AA; Atik AF; Suryadevara CM; Chongsathidkiet P; Fecci PE; Sampson JH
Expert Opin Drug Saf; 2017 Mar; 16(3):277-287. PubMed ID: 27989218
[TBL] [Abstract][Full Text] [Related]
4. Emerging immunotherapies for glioblastoma.
Desai R; Suryadevara CM; Batich KA; Farber SH; Sanchez-Perez L; Sampson JH
Expert Opin Emerg Drugs; 2016 Jun; 21(2):133-45. PubMed ID: 27223671
[TBL] [Abstract][Full Text] [Related]
5. Developing immunotherapeutic strategies to target brain tumors.
Lieberman NA; Moyes KW; Crane CA
Expert Rev Anticancer Ther; 2016 Jul; 16(7):775-88. PubMed ID: 27253692
[TBL] [Abstract][Full Text] [Related]
6. Immunological effects of chemotherapy and radiotherapy against brain tumors.
Weiss T; Weller M; Roth P
Expert Rev Anticancer Ther; 2016 Oct; 16(10):1087-94. PubMed ID: 27598516
[TBL] [Abstract][Full Text] [Related]
7. The Potential of Cellular- and Viral-Based Immunotherapies for Malignant Glioma-Dendritic Cell Vaccines, Adoptive Cell Transfer, and Oncolytic Viruses.
Maxwell R; Luksik AS; Garzon-Muvdi T; Lim M
Curr Neurol Neurosci Rep; 2017 Jun; 17(6):50. PubMed ID: 28488122
[TBL] [Abstract][Full Text] [Related]
8. Immune and viral therapies for malignant primary brain tumors.
Gardeck AM; Sheehan J; Low WC
Expert Opin Biol Ther; 2017 Apr; 17(4):457-474. PubMed ID: 28274139
[TBL] [Abstract][Full Text] [Related]
9. Advances in immunotherapeutic research for glioma therapy.
Miyauchi JT; Tsirka SE
J Neurol; 2018 Apr; 265(4):741-756. PubMed ID: 29209782
[TBL] [Abstract][Full Text] [Related]
10. Towards Immunotherapy for Pediatric Brain Tumors.
Wang SS; Bandopadhayay P; Jenkins MR
Trends Immunol; 2019 Aug; 40(8):748-761. PubMed ID: 31229353
[TBL] [Abstract][Full Text] [Related]
11. [Immunotherapy in brain tumors].
De Carli E; Delion M; Rousseau A
Ann Pathol; 2017 Feb; 37(1):117-126. PubMed ID: 28111040
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy for Pediatric Brain and Spine Tumors: Current State and Future Directions.
Estevez-Ordonez D; Gary SE; Atchley TJ; Maleknia PD; George JA; Laskay NMB; Gross EG; Devulapalli RK; Johnston JM
Pediatr Neurosurg; 2023; 58(5):313-336. PubMed ID: 36549282
[TBL] [Abstract][Full Text] [Related]
13. Concepts of immunotherapy for glioma.
Patel MA; Pardoll DM
J Neurooncol; 2015 Jul; 123(3):323-30. PubMed ID: 26070552
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy in gliomas: Are we reckoning without the innate immunity?
Vismara MFM; Donato A; Malara N; Presta I; Donato G
Int J Immunopathol Pharmacol; 2019; 33():2058738419843378. PubMed ID: 30968718
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy approaches in the treatment of malignant brain tumors.
Dunn-Pirio AM; Vlahovic G
Cancer; 2017 Mar; 123(5):734-750. PubMed ID: 27875627
[TBL] [Abstract][Full Text] [Related]
16. Advances in Immunotherapy for Glioblastoma Multiforme.
Huang B; Zhang H; Gu L; Ye B; Jian Z; Stary C; Xiong X
J Immunol Res; 2017; 2017():3597613. PubMed ID: 28299344
[TBL] [Abstract][Full Text] [Related]
17. Molecular imaging and advanced MRI findings following immunotherapy in patients with brain tumors.
Galldiks N; Lohmann P; Werner JM; Ceccon G; Fink GR; Langen KJ
Expert Rev Anticancer Ther; 2020 Jan; 20(1):9-15. PubMed ID: 31842635
[No Abstract] [Full Text] [Related]
18. Single vs. combination immunotherapeutic strategies for glioma.
Chandran M; Candolfi M; Shah D; Mineharu Y; Yadav VN; Koschmann C; Asad AS; Lowenstein PR; Castro MG
Expert Opin Biol Ther; 2017 May; 17(5):543-554. PubMed ID: 28286975
[TBL] [Abstract][Full Text] [Related]
19. Targeting Innate Immunity in Glioma Therapy.
Gillard AG; Shin DH; Hampton LA; Lopez-Rivas A; Parthasarathy A; Fueyo J; Gomez-Manzano C
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256021
[TBL] [Abstract][Full Text] [Related]
20. Immune Checkpoint Blockade Biology in Mouse Models of Glioblastoma.
Yeo AT; Charest A
J Cell Biochem; 2017 Sep; 118(9):2516-2527. PubMed ID: 28230277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
